Critical Care

official impact factor 4.60
Search for
Advanced search
Critical Care
Tools
Open Access Highly Access

Drotrecogin alfa (activated): real-life use and outcomes for the UK

Kathryn M Rowan*, Catherine A Welch, Emma North and David A Harrison

Critical Care 2008, 12:R58 doi:10.1186/cc6879

Accesses  

  • Last 30 days: 28 accesses
  • Last year: 500 accesses
  • All time: 4426 accesses

Cited by

BioMed Central: 3 citations

Research   Open Access Highly Accessed

Is Drotrecogin alfa (activated) for adults with severe sepsis, cost-effective in routine clinical practice?

M Zia Sadique, Richard Grieve, David A Harrison, Brian H Cuthbertson, Kathryn M Rowan Critical Care 2011, 15:R228 (26 September 2011)

Abstract | Full text | PDF | PubMed

Poster presentation   Free

Drotrecogin alfa (activated): a single-centre experience of 110 patients

S Fletcher, N Pathmanathan Critical Care 2010, 14(Suppl 1):P407 (1 March 2010)

Full text | PDF

Research   Open Access Highly Accessed

The international PROGRESS registry of patients with severe sepsis: drotrecogin alfa (activated) use and patient outcomes

Greg Martin, Frank M Brunkhorst, Jonathan M Janes, Konrad Reinhart, David P Sundin, Kassandra Garnett, Richard Beale Critical Care 2009, 13:R103 (30 June 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations